What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Pathology
Antonio Lopez-Beltran focuses on Pathology, Carcinoma, Urinary bladder, Bladder cancer and Cancer.
In most of his Pathology studies, his work intersects topics such as Transitional cell carcinoma.
The Carcinoma study combines topics in areas such as Multilocular Cystic Renal Cell Carcinoma, Prostate, Anatomical pathology and Adenocarcinoma.
His biological study deals with issues like Prostate cancer, which deal with fields such as Urology.
Antonio Lopez-Beltran studied Bladder cancer and Grading that intersect with Radiology, Papillary urothelial neoplasm of low malignant potential, Who classification, Invasive urothelial carcinoma and Papilloma.
He focuses mostly in the field of Cancer, narrowing it down to topics relating to Oncology and, in certain cases, Carcinogenesis.
His most cited work include:
- The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia (680 citations)
- 2004 WHO Classification of the Renal Tumors of the Adults (611 citations)
- The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters (402 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Pathology, Internal medicine, Oncology, Prostate cancer and Carcinoma.
His Pathology study combines topics from a wide range of disciplines, such as Bladder cancer, Cancer, Adenocarcinoma and Urinary bladder.
His Urinary bladder research is multidisciplinary, incorporating elements of Transitional cell carcinoma, Urinary system and Differential diagnosis.
The study incorporates disciplines such as Clinical trial, Disease and Immunotherapy in addition to Oncology.
His work deals with themes such as Cancer research, Prostate and Biopsy, which intersect with Prostate cancer.
Particularly relevant to Small-cell carcinoma is his body of work in Carcinoma.
He most often published in these fields:
- Pathology (49.02%)
- Internal medicine (25.23%)
- Oncology (21.70%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (25.23%)
- Pathology (49.02%)
- Cancer research (16.86%)
In recent papers he was focusing on the following fields of study:
Antonio Lopez-Beltran mainly investigates Internal medicine, Pathology, Cancer research, Prostate cancer and Oncology.
His Pathology research incorporates elements of Prostatic Acinar Adenocarcinoma and Urinary system.
His Cancer research research is multidisciplinary, incorporating perspectives in Immunohistochemistry, Molecular genetics and Urothelial carcinoma.
His research in Prostate cancer intersects with topics in Immune checkpoint, Grading and Prostate.
The concepts of his Oncology study are interwoven with issues in Bladder cancer, Cancer, Immunotherapy, Clinical trial and Circulating tumor cell.
His studies deal with areas such as Precision medicine, Urine and Urinary bladder as well as Bladder cancer.
Between 2019 and 2021, his most popular works were:
- Epigenetic modulations and lineage plasticity in advanced prostate cancer. (15 citations)
- Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma (13 citations)
- Is There a Role for Immunotherapy in Prostate Cancer (7 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Antonio Lopez-Beltran mainly focuses on Internal medicine, Oncology, Prostate cancer, Cancer research and Immunotherapy.
As part of one scientific family, Antonio Lopez-Beltran deals mainly with the area of Internal medicine, narrowing it down to issues related to the Cytology, and often Malignancy, Likelihood ratios in diagnostic testing, Urinary system and Gastroenterology.
His Oncology research is multidisciplinary, incorporating perspectives in Bladder cancer, Clinical trial, Biomarker and Circulating tumor cell.
His Circulating tumor cell study which covers Transcriptome that intersects with Pathology.
His research links Urothelial carcinoma with Pathology.
His Prostate cancer research includes elements of Immune checkpoint, Clinical endpoint and Prostate.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
